A) Heart rate
Heart rate was recorded for control and patient participants (at rest with interoceptive attentional focus). Differences between controls and the patients as a whole, nor between patient diagnostic subgroups, did not attain threshold significance. Across patients, anxiety symptoms (state) correlated with heart rate (R=0.14 P<.05) but not with measures of depression or anxiety. Heart rate did not differentiate patients on or off antipsychotic nor antidepressant medication.
B) Heart rate variability (HRV)
The patient population as a whole manifest lower heart rate variability compared to controls (HRV RMSSD; patients versus controls; ms mean ± SD: 70.19 ± 58.4 vs 51.6 ± 42.6, F(1)=8.8, P<.005). Depression symptoms correlated negatively with HRV (RMSSDSD R=-0.15, P<.01). There were significant differences in HRV between diagnostic groups of patients (RMSSDSD without age, sex, and BMI covariates: F(6)=3.3, P<.01; with covariates included F(6)=2.4, P<.05). HRV was no different in people on and off antidepressant medication, but significantly lower in patients on antipsychotic medications (RMSSD; antipsychotic vs no antipsychotic; ms mean ± SD: 42.6 ± 31 vs 59.4 ± 48, F(1)=7.1, P<.01).